InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Pamukcu Rifat. Officer active across 1 company, notably Aprea Therapeutics, Inc.. In total, 5 filings have been logged. Activity tracked since 28 July 2022. The latest transaction was filed on 5 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Pamukcu Rifat is a declarant linked to Aprea Therapeutics, Inc. as Director. The profile covers 5 filings in total, and the 5 sampled recent filings run from 2022-08-01 to 2026-06-17, with buy and sell amounts shown as EUR 0.